Previous close | 0.0625 |
Open | 0.0600 |
Bid | 0.0433 x 0 |
Ask | 0.0590 x 0 |
Day's range | 0.0594 - 0.0625 |
52-week range | 0.0430 - 0.5600 |
Volume | |
Avg. volume | 21,490 |
Market cap | 1.969M |
Beta (5Y monthly) | 0.86 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.3900 |
Earnings date | 26 Jul 2024 - 30 Jul 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Lifeist enters into services agreement with Simply Solventless to provide operational support to CannMart and share purchase agreement to sell CannMartTORONTO, June 25, 2024 (GLOBE NEWSWIRE) -- Lifeist Wellness Inc. (“Lifeist” or the “Company”) (TSXV: LFST) (FRANKFURT: M5B) (OTCMKTS: LFSWF), a health-tech company that leverages advancements in science and technology to build breakthrough ventures that transform human wellness, is pleased to announce that each of the Company and CannMart Inc. (“C
Lifeist Sells Non-Core Subsidiary to Sharpen its Strategic Focus on Nutraceuticals and B2B Recreational CannabisTORONTO, June 05, 2024 (GLOBE NEWSWIRE) -- Lifeist Wellness Inc. (“Lifeist” or the “Company”) (TSXV: LFST) (FRANKFURT: M5B) (OTCMKTS: LFSWF), a health-tech company that leverages advancements in science and technology to build breakthrough companies that transform human wellness, today announced the sale of Australian Vaporizers Pty Ltd. (“Aussie Vapes”), its wholly owned Australian su
TORONTO, May 10, 2024 (GLOBE NEWSWIRE) -- Lifeist Wellness Inc. (“Lifeist” or the “Company”) (TSXV: LFST) (FRANKFURT: M5B) (OTCMKTS: LFSWF), a health-tech company that leverages advancements in science and technology to build breakthrough ventures that transform human wellness, today announced that, further to its news release dated April 30, 2024, the TSX Venture Exchange (the "Exchange") has approved the consolidation of the Company’s issued and outstanding common shares on the basis of one (1